A Phase I/II Study of Tazemetostat Combined with Abbreviated Rituximab/Bendamustine Therapy for High Tumor Burden Follicular Lymphoma in Frontline Treatment: A Big Ten Cancer Research Consortium Study - Kenkre, Vaishalee P; Lin, Yong; Epperla, Narendranath; Rajguru, Saurabh A; Chang, Julie E; Pophali, Priyanka A.; Harris, Elyse I; Fletcher, Christopher D; Matasar, Matthew; Eltoukhy, Hussam; Bond, David A.; Sawalha, Yazeed; et al. (Blood, 2024)